Increase in Issued Shares and Capital through the Exercise of Stock Acquisition Rights
First written in FY2019-Q3. 18 of 20 entries say "Advanced", first in FY2019. Latest entry: FY2025.
22 other companies' latest entry also says "Achieved".
- FY2025AchievedAnnual report
「These stock acquisition rights lapsed on 15 October 2025 because the exercise period expired.」
During the current fiscal year, 98,400 shares were issued through the exercise of stock acquisition rights, and the remaining stock acquisition rights lapsed on 15 October 2025 upon expiration of the exercise period. - FY2024-Q2AdvancedAnnual report
「1 January 2024–31 March 2024 (Note) 400 9,037,600 0 436 0 410 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the current quarter, the exercise of stock acquisition rights increased the total number of issued shares by 400 shares, bringing the number of issued shares at period-end to 9,037,600. - FY2024-Q1AdvancedAnnual report
「1 October 2023–31 December 2023 (Note 1) 16,400 9,037,200 0 436 0 410 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights increased the total number of issued shares by 16,400 shares, bringing the number of issued shares at period-end to 9,037,200. - FY2023AdvancedAnnual report
「1 October 2022–30 September 2023 (Note 1) 162,400 9,020,800 3 435 3 409」
During FY2023, the exercise of stock acquisition rights increased the total number of issued shares by 162,400 shares, while capital stock and the capital surplus each increased by ¥3 million, bringing the number of issued shares at period-end to 9,020,800. - FY2023-Q3AdvancedAnnual report
「1 April 2023–30 June 2023 (Note 1) 34,400 9,007,200 0 435 0 409 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, the exercise of stock acquisition rights increased the total number of issued shares by 34,400 shares, bringing the number of issued shares at period-end to 9,007,200. - FY2023-Q2AdvancedAnnual report
「1 January 2023–31 March 2023 (Note 1) 104,000 8,972,800 2 434 2 408」
During the second quarter, the exercise of stock acquisition rights increased the total number of issued shares by 104,000 shares, while capital stock and the capital surplus each increased by ¥2 million. - FY2023-Q1AdvancedAnnual report
「1 October 2022–31 December 2022 (Note 1) 10,400 8,868,800 0 432 0 406 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights increased the total number of issued shares by 10,400 shares, bringing the number of issued shares at period-end to 8,868,800. - FY2022AdvancedAnnual report
「1 October 2021–30 September 2022 (Note 1) 41,200 8,858,400 927 432,098 927 406,098」
During FY2022, the exercise of stock acquisition rights increased the total number of issued shares by 41,200 shares, while capital stock and the capital surplus each increased by ¥927 thousand. - FY2022-Q3AdvancedAnnual report
「1 April 2022–30 June 2022 (Note 1) 5,200 8,840,400 117 431,693 117 405,693 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the current quarter, the exercise of stock acquisition rights increased the total number of issued shares by 5,200 shares, while capital stock and the capital surplus each increased by ¥117 thousand. - FY2022-Q2AdvancedAnnual report
「1 January 2022–31 March 2022 (Note 1) 2,400 8,835,200 54 431,576 54 405,576 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. From 1 April to 30 April 2022, the exercise of stock acquisition rights further increased the total number of issued shares by 4,000 shares, while capital stock and the capital surplus each increased by ¥90 thousand.」
During the second quarter, the exercise of stock acquisition rights increased the total number of issued shares by 2,400 shares, while capital stock and the capital surplus each increased by ¥54 thousand. An additional increase of 4,000 shares through the exercise of stock acquisition rights by the filing date is also stated. - FY2022-Q1AdvancedAnnual report
「1 October 2021–31 December 2021 (Note) 15,600 8,832,800 351 431,522 351 405,522 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the current quarter, the exercise of stock acquisition rights increased the total number of issued shares by 15,600 shares, while capital stock and the capital surplus each increased by ¥351 thousand. - FY2021-Q3AdvancedAnnual report
「1 April 2021–30 June 2021 (Note 1) 1,600 8,814,000 36 431,099 36 405,099 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
During the current quarter, the exercise of stock acquisition rights increased the total number of issued shares by 1,600 shares, while capital stock and the capital surplus each increased by ¥36 thousand. As of the filing date, the number of issued shares was 8,815,200. - FY2021-Q2AdvancedAnnual report
「1 January 2021–31 March 2021 (Note 1) 800 8,812,400 18 431,063 18 405,063 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, the exercise of stock acquisition rights increased the total number of issued shares by 800 shares, while capital stock and the capital surplus each increased by ¥18 thousand. - FY2021-Q1AdvancedAnnual report
「1 October 2020–31 December 2020 (Note) 27,200 8,811,600 612 431,045 612 405,045 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the current quarter, the exercise of stock acquisition rights increased the total number of issued shares by 27,200 shares, while capital stock and the capital surplus each increased by ¥612 thousand. - FY2020AdvancedAnnual report
「1 October 2019–30 September 2020 (Note) 24,400 8,784,400 549 430,433 549 404,433 (Note) Increase resulting from the exercise of stock acquisition rights.」
During FY2020, the exercise of stock acquisition rights increased the total number of issued shares, capital stock and the capital surplus. - FY2020-Q3AdvancedAnnual report
「1 April 2020–30 June 2020 (Note 1) 2,000 8,779,600 45 430,325 45 40,432 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, the exercise of stock acquisition rights increased the total number of issued shares by 2,000 shares, while capital stock and the capital surplus each increased by ¥45 thousand. - FY2020-Q2AdvancedAnnual report
「1 January 2020–31 March 2020 (Note) 16,800 8,777,600 378 430,280 378 404,280 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first six months, the exercise of stock acquisition rights increased the total number of issued shares by 16,800 shares, while capital stock and the capital surplus each increased by ¥378 thousand. - FY2020-Q1AdvancedAnnual report
「1 October 2019–31 December 2019 (Note) 800 8,760,800 18 429,902 18 403,902 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights increased the total number of issued shares by 800 shares, while capital stock and the capital surplus each increased by ¥18 thousand. - FY2019AdvancedAnnual report
「Increase from the exercise of stock options 48,400 shares」
During the current consolidated fiscal year, the exercise of stock acquisition rights increased the total number of issued shares by 48,400 shares, while capital stock and the capital surplus each increased by ¥1.089 million. - FY2019-Q3First statedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From 1 April to 30 June 2019, the total number of issued shares increased by 6,400 shares through the exercise of stock acquisition rights, while capital stock and the capital surplus each increased by ¥144 thousand.